Kaiseraugst, Switzerland

Angela Wildermann

This inventor holds 2 USPTO granted patents and 7 published patent applications and 6 EPO patents. Top assignee: Dsm IP Assets B.v.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angela Wildermann. Retrieved from https://idiyas.com/inventor/angela-wildermann-kc94ac1g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Angela Wildermann - Innovator in Retinol Formulations

Introduction

Angela Wildermann is an accomplished inventor based in Kaiseraugst, Switzerland. She is currently associated with Dsm IP Assets B.V. Although she does not hold any granted patents, her contributions to the field of retinol formulations are noteworthy.

Latest Patent Applications

Angela's latest patent applications include:

1. **Retinol Formulation (VI)** - This invention relates to a new formulation that comprises a high amount of retinol, which has a defined mixture of cis and trans isomers, in a specific solvent and in the presence of mixed tocopherol.

2. **Retinol Formulation (V)** - Similar to her previous application, this invention also focuses on a new formulation with a high amount of retinol, featuring a defined mixture of cis and trans isomers, in a specific solvent and in the presence of mixed tocopherol.

Conclusion

Angela Wildermann is making significant strides in the field of retinol formulations, showcasing her innovative spirit through her latest patent applications. Her work continues to contribute to advancements in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…